-
What We Fund: $51M with an App to Improve Speech and Therapies to Ease Cognition and Stop Disease
February 28, 2023
… that activity may be disease-modifying and neuroprotective. Multiple therapies with this approach are in clinical …
-
PPMI Needs People At Risk for Parkinson’s — Even if Not Diagnosed with PD
March 22, 2021
… companies, dozens of academic Centers of Excellence and multiple governmental entities across nearly three dozen …
-
PPMI Dispatch: New Tool to Measure Risk of Impulse Control Disorders in Parkinson’s
October 25, 2022
… diagnosis , especially if an individual is living with multiple risk factors. These data are useful in …
-
Hope for a “Normal” Life — for Patients and for Families
March 22, 2013
… they leave no promising stone unturned. They’re pursuing multiple targets and working with teams all over the world …
-
Exenatide, a GLP-1 Drug, Shows No Impact on Parkinson’s Symptoms
February 5, 2025
… that might explain the range of results seen to date across multiple prior GLP-1 treatment trials in Parkinson’s. The …
-
Could Genetic Junk Spin Drug Development Gold?
September 6, 2012
… road, lead to new drugs to treat a host of conditions, from multiple sclerosis, to Crohn’s disease, to Celiac disease. …